瑞康医药
(002589)
| 流通市值：38.19亿 | | | 总市值：42.13亿 |
| 流通股本：13.64亿 | | | 总股本：15.05亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,022,756,394.67 | 5,060,786,524.48 | 5,527,494,506.54 | 6,179,217,668.57 |
| 应收票据及应收账款 | 4,173,882,614.65 | 3,980,031,274.02 | 4,168,747,029.98 | 4,192,852,671.09 |
| 其中：应收票据 | 223,149,758.91 | 217,042,949.57 | 260,615,651.39 | 224,374,644.04 |
| 应收账款 | 3,950,732,855.74 | 3,762,988,324.45 | 3,908,131,378.59 | 3,968,478,027.05 |
| 应收款项融资 | 130,828,024.54 | 242,008,979.47 | 295,577,066.44 | 364,304,713.85 |
| 预付款项 | 156,326,480.44 | 97,371,027.52 | 104,449,902.97 | 137,661,867 |
| 其他应收款合计 | 968,760,114.62 | 990,014,899.01 | 1,140,137,985.45 | 1,235,700,426.71 |
| 存货 | 978,041,450.83 | 1,119,070,006.89 | 788,333,085.2 | 876,690,520.89 |
| 其他流动资产 | 53,463,698.1 | 49,809,999.14 | 49,857,697.89 | 70,934,449.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 10,484,058,777.85 | 11,539,092,710.53 | 12,144,597,274.47 | 13,177,362,317.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 671,807,419.45 | 655,387,619.45 | 714,130,122.73 | 435,948,304.55 |
| 其他权益工具投资 | 5,217,561 | 5,217,561 | 5,217,561 | 15,217,561 |
| 其他非流动金融资产 | 191,423,577.02 | 191,423,577.02 | 142,900,000 | 142,900,000 |
| 投资性房地产 | 600,441,662.16 | 605,263,430.46 | 610,216,797.74 | 628,380,046.23 |
| 固定资产 | 1,821,830,436.23 | 1,845,564,712 | 1,923,502,170.02 | 1,986,124,186.97 |
| 在建工程 | 420,812,103.38 | 429,339,745.13 | 351,338,810.06 | 329,130,628.6 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 6,541,717.33 | 2,520,026.49 | 2,750,927.24 | 3,599,250.45 |
| 无形资产 | 531,285,432.6 | 552,391,028.45 | 582,439,630.02 | 592,167,737.73 |
| 开发支出 | - | 0 | - | - |
| 商誉 | 146,667,621.5 | 146,667,621.5 | 146,685,258.04 | 146,685,258.04 |
| 长期待摊费用 | 50,032,699.86 | 60,866,161.19 | 71,013,427.32 | 78,677,495.76 |
| 递延所得税资产 | 243,375,931.04 | 284,444,301.64 | 98,965,683.52 | 81,084,894.14 |
| 其他非流动资产 | 385,444,841.43 | 391,127,536.62 | 633,787,243.45 | 663,932,243.51 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,074,881,003 | 5,170,213,320.95 | 5,282,947,631.14 | 5,103,847,606.98 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 15,558,939,780.85 | 16,709,306,031.48 | 17,427,544,905.61 | 18,281,209,924.56 |
| 流动负债: | | | | |
| 短期借款 | 4,802,284,312.2 | 6,556,061,480.41 | 3,698,017,376.21 | 4,238,554,940.89 |
| 应付票据及应付账款 | 4,234,585,093.18 | 3,722,628,491.71 | 7,059,995,723.8 | 7,285,800,989.97 |
| 其中：应付票据 | 1,506,961,411.23 | 448,598,750.69 | 4,852,622,725.52 | 4,925,296,183.7 |
| 应付账款 | 2,727,623,681.95 | 3,274,029,741.02 | 2,207,372,998.28 | 2,360,504,806.27 |
| 预收款项 | 0 | 0 | - | - |
| 合同负债 | 17,541,023.29 | 29,116,668.24 | 28,255,440.13 | 31,680,906.04 |
| 应付职工薪酬 | 17,868,520.75 | 17,907,481.2 | 17,139,152.43 | 18,297,599.79 |
| 应交税费 | 16,174,318.78 | 14,782,301.91 | 17,140,447.36 | 17,389,583.95 |
| 其他应付款合计 | 368,693,249.12 | 316,910,045.46 | 605,996,522.43 | 639,652,583.34 |
| 其中:应付利息 | - | 0 | - | - |
| 应付股利 | 3,943,415.4 | 3,943,415.4 | 22,090,528.42 | 37,090,528.42 |
| 一年内到期的非流动负债 | 8,994,616.22 | 6,123,925.88 | 10,505,426.83 | 11,079,465.48 |
| 其他流动负债 | 115,730,887.97 | 97,587,210.56 | 79,571,490.65 | 90,487,553.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 9,581,872,021.51 | 10,761,117,605.37 | 11,516,621,579.84 | 12,332,943,622.66 |
| 非流动负债: | | | | |
| 长期借款 | 269,500,000 | 261,273,967.64 | 176,300,000 | 117,600,000 |
| 租赁负债 | 4,642,625.89 | 835,714.42 | 1,062,102.42 | 1,246,288.76 |
| 递延收益 | 1,585,850.03 | 1,619,323.09 | 1,746,345.34 | 1,756,586.5 |
| 递延所得税负债 | 45,791,190.53 | 47,482,426.87 | 35,782,755.72 | 36,843,985.44 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 321,519,666.45 | 311,211,432.02 | 214,891,203.48 | 157,446,860.7 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 9,903,391,687.96 | 11,072,329,037.39 | 11,731,512,783.32 | 12,490,390,483.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 |
| 资本公积 | 3,719,909,185.63 | 3,719,909,185.63 | 3,526,381,929.59 | 3,520,424,279.59 |
| 减:库存股 | 230,651,529.31 | 230,651,529.31 | - | - |
| 盈余公积 | 159,527,095.27 | 159,527,095.27 | 152,771,843.59 | 152,771,843.59 |
| 未分配利润 | 309,467,463.74 | 294,298,491.05 | 299,566,609.65 | 311,013,760.4 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,462,962,686.33 | 5,447,793,713.64 | 5,483,430,853.83 | 5,488,920,354.58 |
| 少数股东权益 | 192,585,406.56 | 189,183,280.45 | 212,601,268.46 | 301,899,086.62 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,655,548,092.89 | 5,636,976,994.09 | 5,696,032,122.29 | 5,790,819,441.2 |
| 负债和股东权益合计 | 15,558,939,780.85 | 16,709,306,031.48 | 17,427,544,905.61 | 18,281,209,924.56 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |